12:00 AM
May 07, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Dymista azelastine/fluticasone regulatory update

FDA approved an NDA from Meda for Dymista azelastine/fluticasone to treat seasonal allergic rhinitis. Meda said Dymista will be available in the U.S. next...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >